IGCS Podcast

In this podcast episode, hear from lead author Anne Sophie Van den Heerik as she discusses the PORTEC 4A trial, the first trial to prospectively investigate a molecular integrated risk profile in patients with high-intermediate risk endometrial cancer. Listeners will learn how PORTEC data informs real-world clinical choices, what the results mean for radiation techniques and toxicity reduction, and how ongoing research continues to...

In this special IGCS podcast episode, we spotlight the United Kingdom’s groundbreaking National Lynch Syndrome Project and its free, globally accessible e-learning modules that equip healthcare professionals with the knowledge and skills to implement genetic testing for Lynch syndrome in gynecologic oncology.

Moderated by Dr. Paul Cohen, Chair of the IGCS Education Committee, this discussion features expert insights on:

• The cl...

The panel explores innovations in surgery, medical therapies—including immunotherapy and targeted treatments—supportive care strategies, and prevention, offering practical takeaways and forward-looking insights to improve patient outcomes.

Moderator: Dr. Brian Slomovitz

Panelists: Dr. Angelica Rodriguez, Dr. Tom Herzog, and Courtney Arn

Special thank you to The GOG Foundation Inc for providing recording support. https://www.gog.org...

Dr. Michael Pearl (USA) discusses end of life decisions, conflicts, and how multidisciplinary teams can support patients, caregivers, and team members in managing unresolved or complex MBO cases.

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and futur...

Dr. Glauco Baiocchi (Brazil) shares when surgery is indicated for MBO, reviewing specific procedures, risks and benefits, and how to apply current evidence to guide surgical decision-making. This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future di...

Dr. Aditi Bhatt (India) discusses non-surgical strategies for managing malignant bowel obstruction, highlighting symptom control, medication use, and the importance of tailoring care based on the site and cause of obstruction.

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical m...

Dr. Eduardo Burera (USA) explores the ethical and emotional complexities of MBO care, highlighting shared decision-making, difficult conversations, and the role of the multidisciplinary palliative care team.

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategie...

Dr. Stephanie Lheureux (Canada) introduces MBO in gynecologic cancers, discussing a through a case presentation and diagnostic challenges, with an emphasis on ovarian cancer and quality of life.

This podcast series explores the complexities of malignant bowel obstruction (MBO) in gynecologic cancer patients, offering expert insights into diagnosis, decision-making, ethics, surgical and non-surgical management strategies, and future...

IGCS nursing workgroup bimonthly tumor board and discussed nursing care options for a vulvar cancer patient with HIV experiencing incomplete treatment and gaps in follow-up.  

Case presentation by Biemba Maliti (Zambia) Moderated by Anne Mellon, RN (Australia), Chrissy Donovan, RN, NP (USA), and Sarah Belton, RN (Ireland) Join future IGCS nursing tumor boards by registering through iECHO.  If have a case you would like to present ...

Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New England Journal of Medicine published article Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.

Click here to read the article

Presented by Brian Slomovitz Director of Gynecologic Oncology  Co-Chair, Cancer Research Committee Mount Sinani Medical Center USA

Moderated by L...

IGCS Education360 Radiation Oncology Workgroup, chaired by Dr. Pearly Khaw, interview with Professor Carien Creutzberg, recipient of the IGCS 2024 Lifetime Achievement Award. She discusses her pioneering work and the significance of international collaboration. Creutzberg reflects on the evolution of research questions in clinical trials, the integration of molecular and immunotherapy advancements, and the importance of multidiscip...